GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Tianyao Pharmaceutical Co Ltd (SHSE:600488) » Definitions » Cash Flow for Dividends

Tianjin Tianyao Pharmaceutical Co (SHSE:600488) Cash Flow for Dividends : ¥-162 Mil (TTM As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Tianjin Tianyao Pharmaceutical Co Cash Flow for Dividends?

Tianjin Tianyao Pharmaceutical Co's cash flow for dividends for the three months ended in Sep. 2024 was ¥-48 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-162 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Tianjin Tianyao Pharmaceutical Co's quarterly payment of dividends increased from Mar. 2024 (¥-8 Mil) to Jun. 2024 (¥-102 Mil) but then declined from Jun. 2024 (¥-102 Mil) to Sep. 2024 (¥-48 Mil).

Tianjin Tianyao Pharmaceutical Co's annual payment of dividends increased from Dec. 2021 (¥-58 Mil) to Dec. 2022 (¥-60 Mil) but then declined from Dec. 2022 (¥-60 Mil) to Dec. 2023 (¥-48 Mil).


Tianjin Tianyao Pharmaceutical Co Cash Flow for Dividends Historical Data

The historical data trend for Tianjin Tianyao Pharmaceutical Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Tianyao Pharmaceutical Co Cash Flow for Dividends Chart

Tianjin Tianyao Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -113.24 -81.05 -58.22 -60.26 -47.75

Tianjin Tianyao Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.02 -3.81 -8.33 -102.03 -47.93

Tianjin Tianyao Pharmaceutical Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-162 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tianjin Tianyao Pharmaceutical Co Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Tianjin Tianyao Pharmaceutical Co's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Tianyao Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 109 Bawei Road, Hedong District, Tianjin, Tianjin, CHN, 300171
Tianjin Tianyao Pharmaceutical Co Ltd is a China-based company engages in the development, manufacture, distribution, and export of pharmaceutical products. Its products include corticosteroids and cardiovascular medicine, dexamethasone, and cortisone acetate.
Executives
Wang Chun Li senior management
Wang Li Feng Directors, senior managers
Wang Shu Li senior management
Zheng Xiu Chun senior management
Liu Xin Directors, senior managers
Wu Sheng senior management
Di Luan Director

Tianjin Tianyao Pharmaceutical Co Headlines

No Headlines